Editorial: Pharmacological and biochemical perspectives of kinase inhibitors in cancer and COVID-19 therapeutics

• Balakumar Chandrasekaran,
• Muthupandian Saravanan

Affiliations

Balakumar Chandrasekaran

Faculty of Pharmacy, Philadelphia University, Amman, Jordan

Muthupandian Saravanan

AMR and Nanotherapeutics Lab, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamilnadu, India